Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$778M |
| 2 |
Walt Disney
DIS
|
+$575M |
| 3 |
Amazon
AMZN
|
+$558M |
| 4 |
Applied Materials
AMAT
|
+$373M |
| 5 |
eBay
EBAY
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$669M |
| 2 |
Philip Morris
PM
|
+$454M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 4 |
Marvell Technology
MRVL
|
+$371M |
| 5 |
Qualcomm
QCOM
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.2% |
| 2 | Financials | 10.85% |
| 3 | Healthcare | 9.88% |
| 4 | Industrials | 8.88% |
| 5 | Consumer Discretionary | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEAD
3701
Teads Holding Co
TEAD
$80M
| $110K | ﹤0.01% |
27,828
| – | – |
|
|
SVM
3702
Silvercorp Metals
SVM
$2.2B
| $107K | ﹤0.01% |
32,855
| – | – |
|
|
AUTL
3703
Autolus Therapeutics
AUTL
$516M
| $106K | ﹤0.01% |
+16,692
| New | +$104K |
|
|
BTA
3704
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $105K | ﹤0.01% |
+10,544
| New | +$108K |
|
3705
Star Group
SGU
$418M
| $105K | ﹤0.01% |
10,500
| – | – |
|
3706
SelectQuote
SLQT
$136M
| $105K | ﹤0.01% |
52,440
+32,870
| +168% | +$49.1K |
|
|
ELEV
3707
DELISTED
Elevation Oncology
ELEV
| $104K | ﹤0.01% |
+20,303
| New | +$65.8K |
|
3708
Nuveen Municipal Income
NMI
$130M
| $97.3K | ﹤0.01% |
+10,301
| New | +$95.8K |
|
|
MRCC
3709
DELISTED
Monroe Capital Corp
MRCC
| $95.9K | ﹤0.01% |
+13,315
| New | +$96.5K |
|
3710
FuboTV Inc
FUBO
$292M
| $94.8K | ﹤0.01% |
5,000
+1,082
| +28% | +$28.2K |
|
3711
Oportun Financial
OPRT
$272M
| $90.6K | ﹤0.01% |
37,279
+3,383
| +10% | +$12.2K |
|
3712
CEMIG Preferred Shares
CIG
$6.21B
| $87.9K | ﹤0.01% |
46,222
-1,279
| -3% | -$2.29K |
|
3713
Quantum-Si Incorporated
QSI
$170M
| $85.9K | ﹤0.01% |
43,600
+29,300
| +205% | +$51.2K |
|
|
STKL
3714
DELISTED
SunOpta
STKL
| $84.8K | ﹤0.01% |
12,350
| – | – |
|
3715
PMV Pharmaceuticals
PMVP
$60.3M
| $84.7K | ﹤0.01% |
49,794
-75,586
| -60% | -$141K |
|
|
ITI
3716
DELISTED
Iteris, Inc.
ITI
| $84.3K | ﹤0.01% |
+17,058
| New | +$84.3K |
|
3717
Ginkgo Bioworks
DNA
$607M
| $84K | ﹤0.01% |
1,811
-313
| -15% | -$16.2K |
|
3718
Equinox Gold
EQX
$7.4B
| $83.9K | ﹤0.01% |
13,942
-48,833
| -78% | -$226K |
|
3719
ImmunityBio
IBRX
$7.07B
| $80.6K | ﹤0.01% |
15,015
-6,085
| -29% | -$27.6K |
|
|
MRSN
3720
DELISTED
Mersana Therapeutics
MRSN
| $80.2K | ﹤0.01% |
716
-924
| -56% | -$91.9K |
|
3721
SkinHealth Systems
SKIN
$97.2M
| $79.7K | ﹤0.01% |
+17,956
| New | +$58.3K |
|
3722
Aclaris Therapeutics
ACRS
$786M
| $78.1K | ﹤0.01% |
62,974
-1,786
| -3% | -$2.13K |
|
|
PMX
3723
DELISTED
PIMCO Municipal Income Fund III
PMX
| $77.7K | ﹤0.01% |
10,396
-14,821
| -59% | -$110K |
|
3724
Ambev
ABEV
$47B
| $75.9K | ﹤0.01% |
30,599
+3,040
| +11% | +$7.92K |
|
3725
Zevra Therapeutics
ZVRA
$605M
| $75K | ﹤0.01% |
12,931
+1,673
| +15% | +$10.3K |
|
Similar funds
Ameriprise's Q1 2024 Portfolio in Review
As of Q1 2024, Ameriprise held 4,016 positions worth $363B, up 8.8% from $334B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Ameriprise's Q1 2024 filing shows 118 new, 1,585 increased, 2,002 reduced and 175 closed positions. Its largest new stake was Arcadium Lithium plc: 13,685,562 shares worth $59M. The largest sale was Lam Research, an estimated $669M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2024 buy was Arcadium Lithium plc: 13,685,562 shares worth $59M.
- Ameriprise added most to Meta Platforms (Facebook) in Q1 2024, an estimated $778M increase.
- Ameriprise's biggest Q1 2024 reduction was Lam Research, cutting an estimated $669M.
- Ameriprise fully exited Livent Corporation in Q1 2024, selling an estimated $120M.
- Ameriprise's ten largest holdings make up 18% of its $363B portfolio in Q1 2024.
- Ameriprise opened 118 new positions and closed 175 in Q1 2024.
- Ameriprise's portfolio value rose 8.8% quarter-over-quarter to $363B.
Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.